Measurement and Modeling of Diffusion Kinetics of a Lipophilic Molecule Across Rabbit Cornea

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2010 Feb 26

PMID 20182774

Citations 6

Authors

Chhavi Gupta

Anuj Chauhan

Raj Mutharasan

Sangly P Srinivas

Affiliations

Soon will be listed here.

Abstract

Purpose: To develop a kinetic model for representing the diffusion and partitioning of Rhodamine B (RhB), a fluorescent lipophilic molecule, across the cornea for gaining insights into pharmacokinetics of topical drugs to the eye.

Methods: Rabbit corneas mounted underneath a custom-built scanning microfluorometer were perfused with Ringers on both sides of the tissue. After a step change in RhB on the tear side, transients of trans-corneal fluorescence of RhB were measured at a depth resolution approximately 8 microm.

Results: RhB distribution exhibited discontinuities at the interface between epithelium and stroma, and between stroma and endothelium. In each of the layers, fluorescence was non-uniform. Fluorescence was elevated in the epithelium and endothelium relative to the stroma. Modeling of RhB transport by diffusion in each layer and stipulation of partitioning of RhB at the cellular interfaces were required to account for trans-corneal penetration kinetics of RhB. The model parameters, estimated using the unsteady state trans-corneal RhB profiles, were found to be sensitive, and the model predicted the experimental profiles accurately.

Conclusions: Conventional pharmacokinetic models that depict cornea as a single compartment do not predict the depth-dependent kinetics of RhB penetration. The proposed model incorporates realistic transport mechanisms and thereby highlights the influence of physicochemical properties of drugs on trans-corneal kinetics.

Citing Articles

Imaging-Based Drug Penetration Profiling in an Excised Sheep Cornea Model.

Viehmeister K, Manuelli A, Guerin C, Kappes S, Lamprecht A Pharmaceutics. 2024; 16(9).

PMID: 39339164 PMC: 11435002. DOI: 10.3390/pharmaceutics16091126.

Computational Model of In Vivo Corneal Pharmacokinetics and Pharmacodynamics of Topically Administered Ophthalmic Drug Products.

German C, Chen Z, Przekwas A, Walenga R, Babiskin A, Zhao L Pharm Res. 2023; 40(4):961-975.

PMID: 36959411 DOI: 10.1007/s11095-023-03480-6.

Quantitative systems pharmacology of the eye: Tools and data for ocular QSP.

Kuepfer L, Fuellen G, Stahnke T CPT Pharmacometrics Syst Pharmacol. 2023; 12(3):288-299.

PMID: 36708082 PMC: 10014063. DOI: 10.1002/psp4.12918.

Corneal epithelial permeability to fluorescein in humans by a multi-drop method.

Srinivas S, Goyal A, Talele D, Mahadik S, Sudhir R, Murthy P PLoS One. 2018; 13(6):e0198831.

PMID: 29920519 PMC: 6007839. DOI: 10.1371/journal.pone.0198831.

Computational modeling of drug transport across the in vitro cornea.

Pak J, Chen Z, Sun K, Przekwas A, Walenga R, Fan J Comput Biol Med. 2017; 92:139-146.

PMID: 29175100 PMC: 5766268. DOI: 10.1016/j.compbiomed.2017.11.009.

References

Urtti A . Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev. 2006; 58(11):1131-5. DOI: 10.1016/j.addr.2006.07.027. View

Wang Y, Chen M, Wolosin J . ZO-1 in corneal epithelium; stratal distribution and synthesis induction by outer cell removal. Exp Eye Res. 1993; 57(3):283-92. DOI: 10.1006/exer.1993.1126. View

Prausnitz M, Noonan J . Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci. 1999; 87(12):1479-88. DOI: 10.1021/js9802594. View

Toropainen E, Ranta V, Talvitie A, Suhonen P, Urtti A . Culture model of human corneal epithelium for prediction of ocular drug absorption. Invest Ophthalmol Vis Sci. 2001; 42(12):2942-8. View

Komai Y, Ushiki T . The three-dimensional organization of collagen fibrils in the human cornea and sclera. Invest Ophthalmol Vis Sci. 1991; 32(8):2244-58. View

Yamamura K, Sasaki H, Nakashima M, Ichikawa M, Mukai T, Nishida K . Characterization of ocular pharmacokinetics of beta-blockers using a diffusion model after instillation. Pharm Res. 1999; 16(10):1596-601. DOI: 10.1023/a:1018964823193. View

MAURICE D, Srinivas S . Use of fluorometry in assessing the efficacy of a cation-sensitive gel as an ophthalmic vehicle: comparison with scintigraphy. J Pharm Sci. 1992; 81(7):615-9. DOI: 10.1002/jps.2600810704. View

Yu B, Kim K, So P, Blankschtein D, Langer R . Topographic heterogeneity in transdermal transport revealed by high-speed two-photon microscopy: determination of representative skin sample sizes. J Invest Dermatol. 2002; 118(6):1085-8. DOI: 10.1046/j.1523-1747.2002.01796.x. View

MAURICE D . Prolonged-action drops. Int Ophthalmol Clin. 1993; 33(4):81-91. DOI: 10.1097/00004397-199303340-00009. View

10.

Srinivas S . In situ measurement of fluorescein release by collagen shields in human eyes. Curr Eye Res. 1994; 13(4):281-8. DOI: 10.3109/02713689408995789. View

11.

Srinivas S, Bonanno J, Lariviere E, Jans D, Van Driessche W . Measurement of rapid changes in cell volume by forward light scattering. Pflugers Arch. 2003; 447(1):97-108. PMC: 4118695. DOI: 10.1007/s00424-003-1145-5. View

12.

Reitsamer H, Bogner B, Tockner B, Kiel J . Effects of dorzolamide on choroidal blood flow, ciliary blood flow, and aqueous production in rabbits. Invest Ophthalmol Vis Sci. 2009; 50(5):2301-7. PMC: 4572513. DOI: 10.1167/iovs.08-2468. View

13.

Gaudana R, Jwala J, Boddu S, Mitra A . Recent perspectives in ocular drug delivery. Pharm Res. 2008; 26(5):1197-216. PMC: 4516219. DOI: 10.1007/s11095-008-9694-0. View

14.

Kim J, Chauhan A . Dexamethasone transport and ocular delivery from poly(hydroxyethyl methacrylate) gels. Int J Pharm. 2008; 353(1-2):205-22. DOI: 10.1016/j.ijpharm.2007.11.049. View

15.

Yu B, Dong C, So P, Blankschtein D, Langer R . In vitro visualization and quantification of oleic acid induced changes in transdermal transport using two-photon fluorescence microscopy. J Invest Dermatol. 2001; 117(1):16-25. DOI: 10.1046/j.0022-202x.2001.01353.x. View

16.

Zhang W, Prausnitz M, Edwards A . Model of transient drug diffusion across cornea. J Control Release. 2004; 99(2):241-58. DOI: 10.1016/j.jconrel.2004.07.001. View

17.

Ranta V, Laavola M, Toropainen E, Vellonen K, Talvitie A, Urtti A . Ocular pharmacokinetic modeling using corneal absorption and desorption rates from in vitro permeation experiments with cultured corneal epithelial cells. Pharm Res. 2003; 20(9):1409-16. DOI: 10.1023/a:1025754026449. View

18.

Araie M, Maurice D . The rate of diffusion of fluorophores through the corneal epithelium and stroma. Exp Eye Res. 1987; 44(1):73-87. DOI: 10.1016/s0014-4835(87)80027-1. View

19.

Friedrich S, Cheng Y, Saville B . Theoretical corneal permeation model for ionizable drugs. J Ocul Pharmacol. 1993; 9(3):229-49. DOI: 10.1089/jop.1993.9.229. View

20.

Guss R, Johnson F, Maurice D . Rhodamine B as a test molecule in intraocular dynamics. Invest Ophthalmol Vis Sci. 1984; 25(6):758-62. View